|MDACC Study No:||2006-0873 (clinicaltrials.gov NCT No: NCT00523809)|
|Title:||Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation with Bevacizumab for Advanced Solid Tumor|
|Principal Investigator:||Naoto Ueno|
|Treatment Agent:||Bevacizumab; Fludarabine; Melphalan|
|Study Description:||The goal of this clinical research study is to learn if giving Avastin |
(bevacizumab) with standard chemotherapy and a blood stem cell transplant, in
patients with an advanced solid tumor, can help to shrink the tumor or slow its
growth. The safety of this treatment will also be studied.